UK universities prove resilience during Horizon hiatus

Before news broke last week of the new Horizon funding deal for the UK, IP law firm Mathys & Squire reported that the UK’s 50 biggest universities filed 433 new patent applications in the period 2021-2022.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com

More on this story

Biotech

Oxford Nanopore scores urgent injunction at UPC in DNA sequencing fight

21 September 2026 Judges agreed with the Oxford University spin-out that MGI Tech was likely to infringe Oxford’s patent, and banned sales of certain Cyclone devices to preserve the one-player-market status quo.

Biotech

Amgen hit with lawsuit over its proposed Opdivo biosimilar

16 September 2026 BMS is stepping up its defence of its blockbuster cancer drug Opdivo as Amgen moves closer to the biosimilar market.

Biotech

Australian biotech sues Grail over multi-cancer blood test

15 September 2026 Grail is facing a patent infringement lawsuit over its Galleri cancer detection test, as Clinical Genomics seeks to enforce its intellectual property while no longer being commercially operational.

More features

Mylan throws down new gauntlet in Novo Wegovy patent fight

New UK High Court judge named as replacement for Justice Meade

US firm hires litigation pro whose clients include Pfizer, Medtronic

Behind the case: How Novartis defended its blockbuster Entresto in the UK

Oxford Nanopore scores urgent injunction at UPC in DNA sequencing fight

Leading European patent litigator to join Carpmaels & Ransford

CIPA Congress: Sustainability is essential for the profession and the planet

Non-profit sues Cambrex over anticancer drug manufacturing trade secrets

UK universities prove resilience during Horizon hiatus

More on this story

Editor's picks

Editor's picks

More features